baber/WOPTO huggingface dataset:
Patent DE-69929528-T2 (DE)
Inventor: MEHIER HENRI
IPC: A61M5/32
Filed: 1999-09-21
Granted: 2006-09-14
Abstract: The invention concerns a device for directly delivering an active substance within all or part of a human or animal tissue cell, characterised in that it is in the form of a hollow tube (1), whereof the walls in contact with said tissue are provided with perforations (5) and whereof the distal end (2) is sealed, while the proximal end (3) is shaped so as to receive removable closing means, said tube being capable of bearing a pressure of at least 50 bars.
Patent DE-69930633-T2 (DE)
Inventor: GUICHARD GERALD
IPC: C09K3/00
Filed: 1999-07-19
Granted: 2007-02-01
Abstract: A functionalized silicone with perfluorinated polyorganosiloxanes (POS) Rf is used to produce coatings with low surface energy and improved adherence to supports. The compositions include a group POS A bearing, per molecule, bis-perfluoromalonate grafts Gf, functional radicals Fa of the amine (HALS) fa1, epoxy fa2, (poly)ether fa3, carboxy fa4 type, and optionally alkyl groups Galk. The invention is useful for producing soil release coatings for textiles.
Patent DE-69933403-T2 (DE)
Inventor: CHRISTENSEN PETER SEIER
IPC: C01B3/38
Filed: 1999-02-08
Granted: 2007-01-11
Abstract: Process for the soot free autothermal steam reforming of a hydrocarbon feedstock by autothermally reforming the feedstock in an autothermal reactor at a given temperature and a given steam to carbon ratio in the feedstock and operating at a pressure in the reactor being above a critical value, where no soot is present in the steam reformed feedstock.
Patent DE-69934324-T2 (DE)
Inventor: PANAYI STAVROS
IPC: A61P29/00
Filed: 1999-10-08
Granted: 2007-07-05
Abstract: The immunoglobulin heavy chain binding protein BiP(GRP78), or a fragment thereof, provides a reagent for indicating the presence of rheumatoid arthritis (RA). The protein used is a recombinant BiP(GRP78) having a defined sequence. A prognostic and/or diagnostic test for RA may be an ELISA or a Western Blot that utilizes the BiP(GRP78) protein or a fragment thereof. Also disclosed are a method of testing for RA using BiP(GRP78) or a cDNA sequence coding therefor. Further disclosed is a method of treating RA by the BiP(GRP78) protein or corresponding cDNA.
Patent HU-E025136-T2 (HU)
Title: Equipment and process for treating pollutants in a soil
Inventor: ILLE CHRISTIAN
IPC: E02D3/12
Filed: 2009-08-13
Abstract: The equipment has a soil treating tool (10) comprising a main injection nozzle (20) for injecting pressurized fluid in the soil and mounted on a lower end of a rotative tubular core (12). Fluid sucking units having a suction pipeline and vacuum pumping units (36), are arranged in an upper part of a bore, and sealing units constituted of pivoting shutters and elastic bellows sealed on an upper part of the bore in which the pressurized fluid rises through boring area surrounding the core, and is destructably maintained by soil agitation units (28, 30). An independent claim is also included for a method for treating pollutant in soil.
Patent HU-E033469-T2 (HU)
Title: Method and apparatus for testing the insulation of a track circuit
Inventor: MORELLI MAURIZIO
IPC: B61L1/20
Filed: 2009-08-25
Abstract: Apparatus for testing the insulation of a direct current track circuit in a railway line provided with a plurality of direct current track circuits adjacent to each other, such circuit comprising a pair of tracks (R) made up of parallel metal sections (B) between which it is possible to apply an electric voltage, each direct current track circuit being separated from the adjacent one through electrically insulating joints (G).
Patent HU-E029086-T2 (HU)
Title: Concentrate for preparing a bouillon, soup, sauce, gravy or for use as a seasoning, the concentrate comprising particulates and xanthan and locust bean gum
Inventor: ACHTERKAMP GEORG
IPC: A23L13/00
Filed: 2006-12-07
Abstract: Concentrates for preparing a bouillon, broth, soup, sauce, gravy or for use as a seasoning, which concentrates comprises 20-80% water, 0.5-60% (pieces of) herbs, vegetables, meat, fish or crustaceans, 3-30% salt and a gelling agent comprising xanthan and locust bean gum.
Patent MD-3394103-T2 (MD)
Inventor: VARGHESE BINDU
IPC: A61P35/02
Filed: 2016-12-21
Abstract: Prezenta invenţie se referă la metode pentru tratarea, reducerea severităţii sau inhibarea creşterii cancerului (de exemplu, a cancerului cu celule B, cum ar fi limfomul Hodgkin sau leucemia limfoblastică acută). Metodele din prezenta invenţie cuprind administrarea la un subiect care are nevoie de aceasta a unei cantităţi terpeutic eficiente de un anticorp sau de un fragment de legare a antigenului acestuia, care se leagă în mod specific de receptorul morţii programate 1 (PD-1), în combinaţie cu o cantitate terapeutic eficientă de un anticorp bispecific, care se leagă în mod specific de CD20 şi CD3.
Patent TR-200102411-T2 (TR)
Inventor: ENNIFAR SOFIANE
IPC: A61K47/48
Filed: 1999-12-01
Abstract: Novel hapten-carrier conjugates are capable of inducing the production of antibodies, in vivo, that specifically bind to nicotine. These conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. The novel conjugates preserve the chirality of nicotine in its native (S)-(-) state, and have good stability properties. The conjugates are useful in formulating vaccines for active immunization, that are used to prevent and treat nicotine addiction. The antibodies raised in response to the nicotine hapten-carrier conjugate are used for passive immunization. These antibodies are administered for prevention and treatment of nicotine addiction.
Patent TR-200103333-T2 (TR)
Title: Dayanıklığı ve biyolojik uygunluğu iyileştiren yardımcı ilaç (SBA)
Inventor: MUELLER RAINER HELMUT
IPC: A61K9/51
Filed: 2000-05-19
Abstract: Bulus, bir veya birçok antijenle birlikte enjekte edildiginde vücut sivilarindan ileri gelen ve selüler bagisiklik tepkisini arttiran dayanikligi ve biyolojik uygunlugu iyilestirilmis bir yardimci ilaç (SBA) içermektedir. Yardimci ilaç kati lipitler ya da kati lipit karisimlari bazinda partiküllerden olusmaktadir. Kullanim olanaklari, daha etkili ve hazmi daha kolay asi maddeleri üretmek, insanlarin ve hayvanlarin asilanmasi, ayni zamanda antikorlarin kazanilmasidir. Partikül büyüklügünun, yükünün ve üst yüzey özelliklerinin seçimiyle bagisiklik tepkisinin gücü hedefli modüle edilebilir ve ilaveten türe uygunlastirilabilir. SBA'ya baska yardimci ilaçlar da örnegin GMDP gibi moleküler yardimci ilaçlar eklenebilir, böylece selüler bagisiklik tepkisi ilaveten arttirilir.
Patent TR-200200820-T2 (TR)
Title: Benzodiazepin türevleri,bunların üretimi ve kullanımları
Inventor: LUBISCH WILFRIED
IPC: A61P9/10
Filed: 2000-09-15
Abstract: Bulus formül (I)'in bilesikleri, hem de bunlarin tautomerik biçimleri, olasi enantiomerik ve diastereomerik biçimleri ile, ve bunlarin ön ilaçlari ve bunlarin kullanimlari ile ilgilidir ki, formüldeki degerlerin anlamlari tarifname içerisinde verilmektedir.Formül (I)
Patent DE-602004002250-T2 (DE)
Inventor: TURRINI ALBERTO
IPC: A61F5/01
Filed: 2004-07-30
Granted: 2007-08-23
Abstract: An articulated joint (15) for an arch support walker (10) comprises at least one crown (23) designed to accommodate a respective disc (27) equipped with a slot (28) involving a predefined circumferential portion of the disc (27), the disc (27) being provided with means of temporary blocking to the crown (23), the temporary blocking means consisting of a pair of radial cursors (33), slidingly housed in respective grooves (32) of the disc (27), and each cursor (33) being equipped with means of elastic loading (35) designed to push it towards the exterior of the disc (27). <IMAGE>
Patent DE-602004002748-T2 (DE)
Inventor: MANZONE ALBERTO
IPC: F02D41/26
Filed: 2004-11-24
Granted: 2007-08-16
Abstract: A drive device for inductive electrical actuators, comprising a power circuit provided with a drive circuit for each electrical actuator and comprising a set of switches to regulate the current flowing through the electrical actuator; the drive device comprising a control circuit which can cause the operation of the power circuit and which comprises a set of control modules, each of which can selectively operate the switches of a corresponding drive circuit, and can supply a state signal (SFLAG) indicating the operating state of the control module; and a synchronization module for receiving and processing the state signals, to generate a common synchronization signal (SSINC); each control module being capable of coordinating the operating actions sent to the switches of the corresponding drive circuit with the operating actions sent by the other control modules to the corresponding switches, in accordance with the synchronization signal. <IMAGE>
Patent DE-602004010024-T2 (DE)
Inventor: FILHOL FABIEN
IPC: B81B3/00
Filed: 2004-09-06
Granted: 2008-09-11
Abstract: The micro-mirror has a movable part (11) with two torsion arms (14) comprising an end (14.1) connected to a fixed part (12) through a bimorph actuation unit (15). The actuation unit has a stack (15.1) packed with arranged or connected layers. The stack has a part (15.3) made up of active material cooperating with a passive flexible structure (15.2), where the material can change volume and/or shape under excitation effect. An independent claim is also included for a method for manufacturing a micro-mirror.
Patent DE-602004011553-T2 (DE)
Inventor: CUTHBERTSON ALAN
IPC: A61K51/04
Filed: 2004-11-12
Granted: 2009-03-26
Abstract: The present invention discloses that imaging agents which comprise a specific type of matrix metalloproteinase inhibitors (MMPi's) of the sulphonamide hydroxamate class labelled with an imaging moiety, are useful diagnostic imaging agents for in vivo imaging and diagnosis of the mammalian body.
Patent DE-602004011623-T2 (DE)
Inventor: RADULESCU ANDREI
IPC: H04L12/56
Filed: 2004-08-10
Granted: 2009-01-29
Abstract: A two-way network interface is provided for both sending transmission messages and receiving reception messages between a pair of processors through a network. The network interface uses transmission messages to transmit both data and information representing respective amounts of unreported buffer space R for receiving data items from reception messages in a buffer storage circuit. The network interface holds up transmission until a number A of data items, that a particular one of the data processing circuits has made available for transmission in the message and for which buffer space is available across the network, exceeds a threshold. However the threshold is lowered, or the transmission message is transmitted before the threshold is exceeded in response to an increase in the amount R of unreported available buffer space in the buffer storage circuit for the particular one of the processing circuits.
Patent DE-602004013320-T2 (DE)
Inventor: ICHAS FRANCOIS
IPC: G01N33/68
Filed: 2004-06-30
Granted: 2009-05-14
Abstract: Process for detecting the occurrence of a particular molecular event in a cell. Process for detecting the occurrence of a particular molecular event in a cell comprises detecting solubilization of a bound protein marker (PM), or binding of a solubilized PM, where PM is a direct or indirect marker of a particular event and is present in the cell before detection. Before detection, the cell is treated to solubilize its plasma membrane so that solubilized protein is released into the extracellular medium and presence of PM is detected, by any suitable method, in the cell or medium so as to determine if solubilization, or binding, and thus the corresponding event, has occurred. Independent claims are also included for the following: (1) PM for use in the new process that comprises a sensitive component (SC), which undergoes solubilization (or binding) and an indicator component (IC) for detection; (2) vector that expresses PM in a cellular environment; (3) transformed cell that expresses PM; (4) non-human transgenic animal in which at least one cell of a certain type expresses PM; and (5) kit for performing the new process that contains cells of (3), the vector of (2) or the animal of (4).
Patent DE-602005003359-T2 (DE)
Inventor: BURTS-COOPER ELLEN
IPC: G11B33/12
Filed: 2005-05-10
Granted: 2008-09-04
Abstract: Internally replenished gas-containing enclosures and methods of internally replenishing an enclosure are described.
Patent DE-60010628-T3 (DE)
Inventor: TIRINEN JUHA
IPC: A63C11/22
Filed: 2000-06-21
Granted: 2009-03-05
Abstract: A pole, for use in skiing or other sport, of the type that includes a grip handle at its upper end, the handle including a support extending from its side wall and adapted to cooperate with the thumb of a user, so as to constitute an additional mechanism for the axial transmission of forces, by the thumb, when the hand is closed on the handle of the pole.
Patent DE-60015042-T3 (DE)
Inventor: KIRCHNER OLIVER
IPC: C12N9/88
Filed: 2000-07-25
Granted: 2008-03-06
Abstract: The invention relates to an isolated polynucleotide comprising a polynucleotide sequence chosen from the group consisting of      a) polynucleotide which is identical to the extent of at least 70 % to a polynucleotide which codes for a polypeptide which comprises the amino acid sequence of SEQ ID No. 2,    b) polynucleotide which is identical to the extent of at least 70 % to a polynucleotide which codes for the polypeptide which is expressed by the dapF gene contained on vector pEC-XT99A-dapF in the deposited C.glutamicum strain DSM 12969,    c) polynucleotide which codes for a polypeptide which comprises an amino acid sequence which is identical to the extent of at least 70 % to the amino acid sequence of SEQ ID No. 2, d) polynucleotide which is complementary to the polynucleotides of a), b) or c), and    e) polynucleotide comprising at least 15 successive bases of the polynucleotide sequence of a), b), c) or d), and a process for the fermentative preparation of L-Lysin with amplification of the dapF gene.  <IMAGE>
Patent DE-69432665-T3 (DE)
Inventor: ROBERTS S
IPC: A61K39/08
Filed: 1994-03-29
Granted: 2007-12-06
Abstract: Novel multicomponent clostridial vaccine formulations using readily dispersible, non-depot adjuvants, such as saponin, are disclosed. The vaccines can be administered to cattle intramusculary or subcutaneously without the severe persistent local reactions, such as granulomas, abscesses, and scarring, normally seen with other multicomponent clostridial vaccines.
Patent DK-1070687-T3 (DK)
Inventor: COURTY PHILIPPE
IPC: B28B3/26
Filed: 2000-06-30
Granted: 2004-01-26
Abstract: The monolithic structure having channels opening at its end faces comprises 70-97 wt.%  alpha - or  beta -silicon carbide and 3-30% wt.% binder ceramic phase of at least one of B2O3, Al2O3, SiO2, MgO, K2O, Li2O, Na2O, CaO, BaO, TiO2, ZrO2 and Fe2O3 and/or a mixed oxide selected from alkali(ne earth) metal aluminosilicates, clays, bentonite, feldspars and other natural aluminosilicate materials. The external shape of the structure is defined by a cylindrical surface bearing on two extreme surfaces having any form. The structure has porosity 35-65 cm<3>/g and pore size distribution of 5-60 microns . The monolithic structure has 7.75-62 channels per cm<2>. The channels have a cross-section of 0.5-9 mm<2>, and the walls separating the channels have a thickness of 0.3-1.5 mm. The channels can be alternately open and closed at either of their ends. The  alpha - or  beta -silicon carbide has at least one, preferably at least two, more preferably two to five, particle size distributions. The average particle size of the silicon carbide is 3-125 microns . Preferably, most of the silicon carbide particles are of size 15-125 microns and a minor part of the silicon carbide particles are of average size less than 15 microns . The ceramic binder phase has an overall composition that is adjusted so that it has a coefficient of expansion close to that of the silicon carbide within a margin of 50%. Independent claims are given for (a) a method of producing the monolithic structure; and (b) use of the monolithic structure as a filter for filtering particles from diesel engine exhaust gas. Production of the monolithic structure involves: (i) mixing the components to form a homogeneous product in the form of a bound paste; (ii) extruding the product through a die so as to form a monolithic honeycomb structure; (iii) drying the obtained structure; (iv) calcining the structure at not more than 1650 degrees C in an oxygen-containing atmosphere; and (v) plugging one channel out of two at each end of the structure. The latter stage (v) can be carried out at any stage of the process after extrusion.
Patent DK-1307411-T3 (DK)
Inventor: HOEHN HERIBERT
IPC: C04B28/12
Filed: 2001-08-07
Granted: 2004-07-12
Abstract: A method for producing concrete or mortar based on an exclusively vegetal aggregate, a mineral binding agent, and mixing water is described. Instead of the vegetal aggregate being premineralized in a separate step of the operation, 4 to 14 kg of a non-hydratizable, finely ground mineralizator is added for each cubic meter of vegetable aggregate when the concrete or mortar is being mixed. Raw calcium carbonate is a preferred mineralizator.
Patent DK-1274589-T3 (DK)
Inventor: VAN DE MEER RONALD
IPC: B41F13/10
Filed: 2001-09-19
Granted: 2004-04-05
Abstract: The invention relates to a jacket assembly for an impression cylinder, comprising a rigid inner jacket (20, 22) that can be fixated on the impression cylinder, and a thin-walled printing form jacket (10) that can be axially slipped onto the inner jacket and that is provided with the printing surface (16). The inner jacket (22) is provided with a compressible layer (24) on its outer periphery and the printing form jacket (10) is designed as a flexible film jacket (12) with a wall thickness of less than 0.5 mm on which the printing surface (16) is fastened. The inventive design allows for lower production, storage and replacement costs in the production of printing forms as compared to conventional jacket assemblies.
Patent DK-1356062-T3 (DK)
Inventor: HUANG HUANG
IPC: C12N15/86
Filed: 2001-10-30
Granted: 2006-05-15
Abstract: The present invention relates to a recombinant DNA construct comprising a YAC vector and at least a portion of the HCMV genome. The vector is useful as a basic research tool with which to study CMV biology, or as a vaccine with which to immunize a mammalian host against infection by CMV.
Patent DK-1383990-T3 (DK)
Inventor: MARRECAU WILLY
IPC: B01D46/24
Filed: 2002-01-31
Granted: 2006-07-17
Abstract: An electrically regeneratable filter element comprises at least two flanks, each of these flanks comprising a stiff material layer. Each of these flanks has at least one thermally and electrically insulated side. The filter element comprises further a metal fiber fleece being pleated according to pleating lines providing an edge with pleat openings. The metal fiber fleece is mounted between the flanks, in such a way that the thermally and electrically insulated sides make contact with the edge, meanwhile these sides closing the pleat openings.
Patent DK-1365810-T3 (DK)
Inventor: BARON JOHN A
IPC: A61K31/194
Filed: 2002-02-14
Granted: 2010-05-10
Abstract: A method for promoting prostate helath in a subject comprising administering a dose of calcium to the subject.  Particularly provided is a method for reducing the risk of prostate carcinomas, comprising administering a dose of elemental calcium effective to reduce the risk of prostate cancer.  In an example, 1200 mg of elemental calcium (supplied in 3000 mg of calcium carbonate) administered twice daily resulted in decreased risk of prostate cancer.
Patent DK-1397935-T3 (DK)
Inventor: JOERGENSEN PETER BREINHOLM
IPC: H04L12/56
Filed: 2002-06-24
Granted: 2012-05-14
Abstract: In a system (e.g. a IR or RF based wireless remote control system) comprising a number (N) of non-synchronized transmitters that transmit respective signals, a method of transmitting data in packets to a receiver, comprising the steps of: transmitting the respective signals, said signals having repeated burst periods that are separated by quiescent periods and repeated with mutually different repetition period, wherein the burst periods have substantially the same length, BL, and each burst period comprises a data packet. The method is characterized in that (I) where N denotes the number of transmitters, n is an index denoting a respective one of the N transmitters, RP<SUB>n </SUB>is the repetition period for a transmitter with index n, and BL is the length of the burst periods.
Patent DK-1409431-T3 (DK)
Inventor: MOSQUET MARTIN
IPC: C04B28/16
Filed: 2002-07-23
Granted: 2007-03-26
Abstract: Polymers of methacrylic acid, partly esterified with mono-alkyl-polyalkylene glycol, are used as dispersants for aqueous compositions of anhydrous calcium sulfate; these dispersants make it possible to improve the maintenance of fluidity and to control the time of onset and/or end of setting.  The use of a dispersant (I) for aqueous compositions of anhydrous calcium sulfate (II) which makes it possible to improve the maintenance of fluidity over time and to control the time of onset and/or completion of setting. This dispersant (I) comprises at least 75% (by number) of random linear chains made up of units of formula (1) and (2), with units of type (2) making up 5-60% of the total (1 + 2) and with oxypropylene groups being distributed randomly (or not) between the oxyethylene groups. X = H, alkali or alkaline earth metal, or ammonium;  n = 1-250;  m = 0-100 with m being less than n;  R = 1-12C alkyl. Independent claims are also included for: (1) the use for the same application of a mixture of dispersants comprising 50-90 wt% (I) and 10-50 wt% of another dispersant (IA) containing at least 75% polymer chains with units of formula (3) and (4) (2)  aqueous compositions of (II) containing (I) (3)  aqueous compositions of (II) containing mixtures of (I) and (IA) as defined above (4)  mixtures of (I) and (IA) as defined above. X1, p, q, R1  =  as defined for X, n, m and R respectively (same or different in each case).
Patent DK-1492417-T3 (DK)
Inventor: YAN NIANXI
IPC: A61K47/42
Filed: 2003-04-08
Granted: 2007-02-26
Abstract: Microcapsules comprising an agglomeration of primary microcapsules, each individual primary microcapsule having a primary shell and the agglomeration being encapsulated by an outer shell, may be prepared by providing an aqueous mixture of a loading substance and a shell material, adjusting pH, temperature, concentration and/or mixing speed to form primary shells of shell material around the loading substance and cooling the aqueous mixture until the primary shells agglomerate and an outer shell of shell material forms around the agglomeration. Such microcapsules are useful for storing a substance and for delivering the substance to a desired environment.
Patent DK-1532346-T3 (DK)
Inventor: CAMPBELL SAMUEL EVERETT
IPC: C09K8/54
Filed: 2003-08-20
Granted: 2008-09-22
Abstract: Disclosed is a method for introducing additives into an oil, gas, or water injection well or pipeline in solid form at a location other than at the bottom. The method is practiced using pellets having a density sufficient to suspend the pellet at a top phase, bottom phase or at the interface of two phases of fluid within a wellbore. The pellets are prepared from a pellet matrix, such as an ethoxylated wax, and a weighting agent as well as an additive. By varying the amount of weighting agent, the density of the pellet can be varied to suspend it at a desired point to for a time sufficient to deliver the additive to the desired point within the wellbore.
Patent DK-1603598-T3 (DK)
Inventor: MERLO ADRIAN
IPC: A61K51/06
Filed: 2004-03-18
Granted: 2009-01-26
Abstract: Radionuclide labelled conjugates based on substance P and analogues thereof with the chelator (DOTAGA) (1-(1-rarboxy-3-carboxy-propyl)-4,7,10(carboxymethyl)-1,4,7,10-tetraazacyclo-dodecane, DOTASA (1-(1-carboxy-2carboxy-ethyl)-4,7,10(carboxymethyl)1,4,7,10-tetraazacyclo-dodecane, or chelator (DOTA) [1,4,7,10 tetraazaacyclo-dodecane 1,4,7,10-tetra(acetic acid)] are useful radiopharmaceutical substances for targeting and treatment of brain tumors, especially gliomas.